Viewing Study NCT05940935


Ignite Creation Date: 2025-12-24 @ 10:21 PM
Ignite Modification Date: 2026-01-01 @ 10:59 PM
Study NCT ID: NCT05940935
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2023-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
Sponsor: Trakya University
Organization:

Study Overview

Official Title: The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations; Does Topiramat or Zonisamide Cause Metabolic Acidosis?
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The relationship of developing metabolic acidosis with antiepleptic drugs in craniotomy operations
Detailed Description: Metabolic acidosis is a life-threatening complication in the perioperative, intraoperative and postoperative period. It can cause decreased cardiac output, electrolyte imbalance, surgical bleeding and neurological complications, even coma and death in surgical patients.

Topiramate and zonisamide are sulfonamide derivative compounds used in the treatment of epilepsy. It has been shown in studies that both drugs have a strong inhibition of carbonic anhydrase enzyme. Recent case reports suggest that both drugs may cause metabolic acidosis by lowering serum bicarbonate levels in some patients.

Aim in this study is to determine the relationship between preoperative, intraoperative and postoperative metabolic acidosis and to emphasize the importance of anesthesia management in patients who have undergone craniotomy and use antiepileptic drugs.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: